We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $171B
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
Cap. Flow
+$6.93B
Cap. Flow %
4.05%
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133

Sector Composition

Rank Sector Weight
1 Miscellaneous 73.8%
2 Technology 9.57%
3 Financials 3.79%
4 Industrials 2.49%
5 Healthcare 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLK icon
1476
Telkom Indonesia
TLK
$14.8B
$4.6M ﹤0.01%
342,709
+69,064
+25% +$1.15M
FVD icon
1477
First Trust Value Line Dividend Fund
FVD
$8.13B
$4.6M ﹤0.01%
95,488
-2,618
-3% -$125K
GRPM icon
1478
Invesco S&P MidCap 400 GARP ETF
GRPM
$513M
$4.59M ﹤0.01%
35,296
-7,035
-17% -$886K
PVH icon
1479
PVH
PVH
$3.33B
$4.56M ﹤0.01%
61,403
+8,359
+16% +$716K
DSGX icon
1480
Descartes Systems
DSGX
$6.43B
$4.56M ﹤0.01%
65,836
-1,132
-2% -$80.8K
HXL icon
1481
Hexcel
HXL
$6.88B
$4.55M ﹤0.01%
45,477
+4,309
+10% +$390K
HLNE icon
1482
Hamilton Lane
HLNE
$4.45B
$4.55M ﹤0.01%
57,711
+36,823
+176% +$3.27M
FIG
1483
Figma
FIG
$12.4B
$4.55M ﹤0.01%
251,475
-21,884
-8% -$440K
BC icon
1484
Brunswick
BC
$4.7B
$4.55M ﹤0.01%
53,988
+2,648
+5% +$212K
PTCT icon
1485
PTC Therapeutics
PTCT
$5.8B
$4.54M ﹤0.01%
55,712
+13,516
+32% +$976K
STRA icon
1486
Strategic Education
STRA
$1.79B
$4.53M ﹤0.01%
59,114
-940
-2% -$74.4K
SPHD icon
1487
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.42B
$4.53M ﹤0.01%
89,012
+768
+0.9% +$38.4K
PRAX icon
1488
Praxis Precision Medicines
PRAX
$9.82B
$4.52M ﹤0.01%
13,512
-2,774
-17% -$878K
ST icon
1489
Sensata Technologies
ST
$6.29B
$4.51M ﹤0.01%
94,553
+23,737
+34% +$1.07M
AMX icon
1490
America Movil
AMX
$68.5B
$4.5M ﹤0.01%
173,099
+14,944
+9% +$393K
KMX icon
1491
CarMax
KMX
$8.64B
$4.5M ﹤0.01%
85,016
-50,824
-37% -$2.21M
ROIV icon
1492
Roivant Sciences
ROIV
$29.6B
$4.5M ﹤0.01%
127,031
+5,471
+5% +$162K
AROC icon
1493
Archrock
AROC
$5.76B
$4.5M ﹤0.01%
110,422
+15,644
+17% +$576K
CTRE icon
1494
CareTrust REIT
CTRE
$9.33B
$4.48M ﹤0.01%
111,138
+9,984
+10% +$392K
SHBI icon
1495
Shore Bancshares
SHBI
$782M
$4.48M ﹤0.01%
195,323
+20,325
+12% +$413K
PHO icon
1496
Invesco Water Resources ETF
PHO
$1.99B
$4.48M ﹤0.01%
64,890
-602
-0.9% -$40.6K
GTLB icon
1497
GitLab
GTLB
$7.91B
$4.48M ﹤0.01%
146,602
+68,505
+88% +$1.74M
RDN icon
1498
Radian Group
RDN
$4.79B
$4.46M ﹤0.01%
118,507
+33,603
+40% +$1.19M
AZZ icon
1499
AZZ Inc
AZZ
$4.22B
$4.46M ﹤0.01%
28,782
+6,001
+26% +$853K
KFRC icon
1500
Kforce
KFRC
$917M
$4.46M ﹤0.01%
95,089
+37,169
+64% +$1.52M

Similar funds

Creative Planning's Q2 2026 Portfolio in Review

As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.

  • Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
  • Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
  • Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
  • Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
  • Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
  • Creative Planning opened 337 new positions and closed 133 in Q2 2026.
  • Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.